Vitamin C and pre-eclampsia

To evaluate the effects of vitamin C supplements on pre-eclampsia in Mulago hospital, Kampala, Uganda

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201210000418271

Enrollment

932

Registered

2012-09-24

Start date

2011-11-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circulatory System Pregnancy and Childbirth Pre-eclampsia

Interventions

vitamin C tablets

placebo

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: pregnant women (primigravida or multigravida) gestational age 12-24 weeks age 15-49 years normal blood pressure lived 15 km or less from hospital willing to deliver at the hospital

Exclusion criteria

Exclusion criteria: serious medical conditions e.g. sickle cell disease or cardiac disease taking vitamin C supplements >200mg/day had contraindications to vitamin C

Design outcomes

Primary

Measure	Time frame
pre-eclampsia	—

Secondary

Measure	Time frame
preterm delivery;adverse neonatal outcomes	—

Countries

Uganda

Contacts

Public ContactPius Okong

Professor

mrokong@gmail.com+256 772 982 903

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026